Sartorius AG PRF PERPETUAL EUR SRT3
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €256.90
- Day Range
- €254.80–261.40
- 52-Week Range
- €168.35–629.60
- Bid/Ask
- €260.40 / €261.90
- Shares Outstanding
- 69.05M
- Market Cap
- €17.97B
- Volume/Avg
- 15 / 651
Key Statistics
- Price/Earnings (Normalized)
- 75.27
- Price/Sales
- 4.85
- Dividend Yield (Trailing)
- 0.29%
- Dividend Yield (Forward)
- 0.29%
- Dividend Payment Schedule
- Mar
- Total Yield
- 0.29%
Company Profile
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Growth
- Total Number of Employees
- 14,279
- Website
- https://www.sartorius.com
Competitors
Valuation
|
Metric
|
SRT3
|
MRK
|
MTD
|
|---|---|---|---|
Price/Earnings (Normalized) | 75.27 | 17.06 | 35.61 |
Price/Book Value | 6.14 | 1.98 | 2,497.00 |
Price/Sales | 4.85 | 2.83 | 7.88 |
Price/Cash Flow | 24.56 | 13.15 | 30.38 |
Price/Earnings
SRT3
MRK
MTD
Financial Strength
|
Metric
|
SRT3
|
MRK
|
MTD
|
|---|---|---|---|
Quick Ratio | 0.48 | 0.99 | 0.65 |
Current Ratio | 1.14 | 1.69 | 1.12 |
Interest Coverage | 3.66 | 7.22 | 16.83 |
Quick Ratio
SRT3
MRK
MTD
Profitability
|
Metric
|
SRT3
|
MRK
|
MTD
|
|---|---|---|---|
Return on Assets (Normalized) | 3.06% | 4.75% | 26.25% |
Return on Equity (Normalized) | 10.99% | 8.32% | — |
Return on Invested Capital (Normalized) | 4.84% | 6.65% | 48.46% |
Return on Assets
SRT3
MRK
MTD
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|%XPv@??v | LOCK|@<Z | $148B | |||
| Becton Dickinson & Co
BDX
| LOCK|<T | LOCK|%<<l | $51B | |||
| ResMed Inc
RMD
| LOCK|txDpSM@ | LOCK|yXz^C | $33B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|lx><y> | LOCK|zMnGQ | $32B | |||
| Alcon Inc
ALC
| LOCK|lCJ!<GZ | LOCK|G>vR | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|Xk?Wcr% | LOCK|JD@ | $26B | |||
| Solventum Corp
SOLV
| LOCK|k&GbRJD | LOCK|#^ | $15B | |||
| Baxter International Inc
BAX
| LOCK|JK | LOCK|&nt>$ | $13B | |||
| Repligen Corp
RGEN
| LOCK|^@R$l>n$ | LOCK|&T%sb | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|&gT&w$ | LOCK|jDs<M | $10B |
United States